72182-70-8

Basic information

• Product Name: 1-BROMO-2-METHYL-D3-PROPANE-3,3,3-D3
• Synonyms: 1-BROMO-2-METHYL-D3-PROPANE-3,3,3-D3
• CAS NO: 72182-70-8
• Molecular Formula: C₄H₉Br
• Molecular Weight: 143.06
• Mol File: 72182-70-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-BROMO-2-METHYL-D3-PROPANE-3,3,3-D3(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BROMO-2-METHYL-D3-PROPANE-3,3,3-D3(72182-70-8)
• EPA Substance Registry System: 1-BROMO-2-METHYL-D3-PROPANE-3,3,3-D3(72182-70-8)

Safety Data

• Hazardous Substances Data: 72182-70-8(Hazardous Substances Data)

Usage

Type

Deuterated analogue of 1-bromo-2-methylpropane (tert-butyl bromide)

Physical state

Colorless liquid

Odor

Faint but distinct

Usage

Widely used in organic synthesis

Applications

a. Preparation of ethers
b. Preparation of esters
c. Synthesis of other organic compounds
d. Formation of carbon-carbon bonds
e. Production of pharmaceuticals and agrochemicals

Deuterated form purpose

Used in research and industrial applications for studying chemical reactions and processes using NMR spectroscopy.

Upstream product

• 72182-69-5 [2',2',2',3,3,3-2H]6-isobutanol 

Downstream Products

• 72182-71-9 1-Phenyl-2,2,4-trimethyl-pentan-1-on-d⁽⁶⁾ 

Relevant articles and documents

MAGNETIC RESONANCE IMAGING DRUG CONTAINING A DEUTERATED NATURAL BRANCHED-CHAIN AMINO ACID, AND DIAGNOSTIC METHOD USING SAID DRUG

The invention relates to the means for magnetic resonance imaging of oncological diseases and other diseases, accompanied by a locally altered level of absorption of nutrients by cells. The invention is the diagnostic drug containing at least one deuterated derivative of a natural branched-chain amino acid, as well as the diagnostic method based on the use of this diagnostic drug. The method of the invention includes performing magnetic resonance imaging and / or deuterium magnetic resonance spectroscopy after administration of the diagnostic drug in a time sufficient for the accumulation of the diagnostic drug in a target area of a subject's body. The proposed method allows to carry out a highly informative diagnostics of oncological diseases and other diseases, accompanied by a locally altered level of absorption of nutrients by cells.